Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 14, 2020JAMAOpen Access

Emergency Use Authorization of Remdesivir

View Full Paper
Ask AI
Bookmark
Share

Authors

MIMichael G. IsonNorthwestern UniversityCWCameron R. WolfeDuke UniversityHBHelen W. BoucherCNR de la Résistance aux Antibiotiques

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Ison et al. (2020) studied this question.

synapsesocial.com/papers/6ab8a1fd9660f9d384ca567ehttps://doi.org/10.1001/jama.2020.8863
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Infectious Diseases Society of America1969 · 3,304 citations
  2. 2The Emergency Use Authorization of Peramivir for Treatment of 2009 H1N1 Influenza2009 · 185 citations
  3. 3The Equitable Distribution of COVID-19 Therapeutics and Vaccines2020 · 165 citations
  4. 4Emergency Use Authorization for Intravenous Peramivir: Evaluation of Safety in the Treatment of Hospitalized Patients Infected With 2009 H1N1 Influenza A Virus2012 · 51 citations
  5. 5Prediction of Creatinine Clearance from Serum Creatinine2008 · 15,448 citations